- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/06 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Patent holdings for IPC class C07C 235/06
Total number of patents in this class: 242
10-year publication summary
21
|
18
|
17
|
14
|
25
|
13
|
25
|
12
|
15
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alnylam Pharmaceuticals, Inc. | 1134 |
19 |
Shin-Etsu Chemical Co., Ltd. | 5446 |
8 |
Laboratorio Farmaceutico C.T. S.r.l. | 19 |
7 |
Japan Atomic Energy Agency | 91 |
6 |
XenoPort, Inc. | 100 |
6 |
Arbor Pharmaceuticals, LLC | 75 |
5 |
Oregon Health & Science University | 758 |
5 |
Acuitas Therapeutics Inc. | 101 |
4 |
Modular Genetics, Inc. | 24 |
4 |
Rutgers, The State University of New Jersey | 1844 |
4 |
Envista | 4 |
4 |
Suzhou Abogen Biosciences Co., Ltd. | 65 |
4 |
Hangzhou Jitai Pharmaceutical Technology Co.,Ltd | 34 |
4 |
Beijing Jitai Pharmaceutical Technology Co.,Ltd | 30 |
4 |
BASF SE | 20432 |
3 |
Commissariat à l'énergie atomique et aux energies alternatives | 10692 |
3 |
Arbutus Biopharma Corporation | 189 |
3 |
Arkema France | 3889 |
3 |
MedImmune Limited | 622 |
3 |
Mitsubishi Gas Chemical Company, Inc. | 3343 |
3 |
Other owners | 140 |